The Medicare Advantage market has seen unprecedented growth in recent years, with a majority of Medicare eligible beneficiaries enrolling in one of these privately administered plans in...

On a new episode of the Gist Healthcare podcast, Joyjit Saha Choudhury joins host J. Carlisle Larsen to talk about his recent piece, Preparing for Medicare Advantage’s Make-or-Break Moment.

Solo living is becoming much more common in American society. As the concept of the American family shifts, and in this case, unwinds, healthcare leaders need to be attuned to new demands—and nimble enough to meet them.

Health systems with substantial energy infrastructure may derive significant value from an energy-as-a-service (EaaS) partnership. Knowing what your health system wants from the partnership will help you identify the right structure for a successful partnership that aligns with your objectives.

This week’s graphic dives into how individual coverage health reimbursement arrangements (ICHRAs), a relatively new coverage option, are being received in the market.

The FTC finalizes its premerger notification rule, Walgreens announces over 1K closures, and providers win a large antitrust class action settlement.

Care transition challenges are particularly acute for academic hospitals, driven in part by their unique tripartite academic mission. Learn how academic hospitals can apply the characteristics of high-performing hospitals to improve their care transitions and patient length of stay.

On today’s episode of the Gist Healthcare podcast, we take a look at some of the healthcare issues that have become platforms for the presidential tickets, as well as how some down ballot races are approaching healthcare policy. Dan Diamond, national healthcare reporter for the Washington Post, joins us to talk healthcare policy and politics.

This week’s graphic dives into a growing challenge facing health systems’ physician enterprises.

VP Harris proposes that Medicare cover home health aides, four health systems launch a new company, and CMS releases its initial list for $2 generic drugs.